What to report
Portal messages should give the clinician decision-ready facts
Online peptide therapy messages are most useful when they are specific. Include the active ingredient, route, strength, when the symptom or question started, what changed since the last visit, and whether any labels, labs, photos, or pharmacy instructions are relevant. This helps the clinician decide whether the plan still fits without relying on vague wellness claims.
- For GLP-1 care, report persistent nausea, vomiting, diarrhea, constipation, reflux, dehydration symptoms, low-blood-sugar concerns, abdominal pain, missed doses, or medication access problems.
- For PT-141/bremelanotide, report nausea, flushing, blood-pressure concerns, cardiovascular symptoms, response patterns, use-frequency questions, and whether the indication still fits.
- For sermorelin, NAD+, glutathione, GHK-Cu, or methylene blue, describe the goal, side effects, medication or supplement overlap, route-specific irritation, and whether expectations remain realistic.